ETHICON Launches the Latest Innovation in Hernia Repair Platform
PROCEED™ Ventral Patch (PVP™ Device)
Somerville, NJ . - ETHICON, INC, a global medical device company, today announced the launch of the PROCEED Ventral Patch (PVP Device), the latest addition to its family of hernia products. PVP Device is the first and only umbilical hernia repair device featuring lighter-weight mesh and exclusive, absorbable deployment technology. It is indicated for use in umbilical, epigastric, small ventral and trocar site hernias.
Hernias are extremely common. Umbilical hernias occur near the belly button or navel, which has a natural weakness from the blood vessels of the umbilical cord. These hernias may occur in infants at or just after birth, and may resolve at 3 or 4 years of age. However, the area of weakness can persist throughout life and can occur in men, women, and children at any time. In adults, umbilical hernias will not resolve and may progressively worsen over time. They are sometimes caused by abdominal pressure due to being overweight, excessive coughing, or pregnancy.
The PROCEED Ventral Patch is a sterile, self-expanding, partially absorbable, flexible mesh device that utilizes the proven design of PROCEED Surgical Mesh. The unique product design offers surgeons secure and stable deployment,1 strength without ePTFE (expanded polytetrafluoroethylene),2 and a macroporous / partially absorbable construction.3 The PVP Device is available in small (4.3 cm) and medium (6.4 cm) sizes.
Dr. Carl Doerhoff, the first surgeon to implant the PVP Device in a human patient in the US, stated, “I’m very excited about the new technology advancements present in the PVP Device. Knowing that the product is flexible and partially absorbable for a greater likelihood of long-term patient comfort is an added benefit.”
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.